サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1437827

ビタミンB12サプリメントの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 形態別、最終用途産業別、地域別

Vitamin B12 Supplement Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 250 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ビタミンB12サプリメントの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 形態別、最終用途産業別、地域別
出版日: 2024年02月13日
発行: Fairfield Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のビタミンB12サプリメントの市場規模は、2024年から2031年にかけて8.0％のCAGRで拡大し、2031年末には5億米ドルに達すると予測されています。

世界のビタミンB12サプリメント市場は、主に健康的なライフスタイルを維持することの重要性に対する人々の意識の高まりによって、顕著な成長を遂げています。特に発展途上国におけるビタミン欠乏症の増加や菜食主義の普及といった要因が、サプリメント需要の急増に大きく寄与しています。最近の研究によると、ベジタリアンとビーガンの食生活が世界的に普及しており、それぞれ人口の11％と3％を占めていることから、ビタミンB12の代替供給源の必要性が強調されています。さらに、世界保健機関（WHO）が強調しているように、発展途上国で蔓延している栄養失調関連の健康問題は、ビタミンB12補給の必要性をさらに強調しています。

北米はビタミンB12サプリメントの顕著な市場として浮上しており、米国だけが大幅な成長を示し、2031年までに1億6,000万米ドルの市場価値に達すると予測されています。菜食主義者やベジタリアンの食生活の増加が、消化器系疾患と闘う人口の多さと相まって、この地域のサプリメントに対する旺盛な需要を裏付けています。カナダもまた、肉を使わない食生活を選び、消化器系の健康問題を経験する人口が多いことから、有利なビジネスチャンスをもたらしています。

米国では、ビーガンやベジタリアンのライフスタイルを取り入れる人々の増加により、ビタミンB12サプリメント市場は2031年までに2,530万米ドルに達すると予想されています。人口の約3％が菜食主義者であり、7％が菜食主義者です。

栄養強化食品を通じたビタミンB12サプリメント市場は、健康と栄養に対する意識の高まりに牽引され、力強い成長が見込まれます。食品強化は、栄養不足に対処するための費用対効果の高いソリューションであり、メーカーは強化製品に対する消費者の需要を満たすために研究開発に投資しています。

当レポートでは、世界のビタミンB12サプリメント市場について調査し、市場の概要とともに、形態別、最終用途産業別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界のビタミンB12サプリメント市場の見通し、2018年～2031年

  • 世界のビタミンB12サプリメント市場の見通し、形態別、金額（100万米ドル）、2018年～2031年
  • 世界のビタミンB12サプリメント市場の見通し、最終用途産業別、金額（100万米ドル）、2018年～2031年
  • 世界のビタミンB12サプリメント市場の見通し、地域別、金額（100万米ドル）、2018年～2031年

第4章 北米のビタミンB12サプリメント市場の見通し、2018年～2031年

第5章 欧州のビタミンB12サプリメント市場の見通し、2018年～2031年

第6章 アジア太平洋のビタミンB12サプリメント市場の見通し、2018年～2031年

第7章 ラテンアメリカのビタミンB12サプリメント市場の見通し、2018年～2031年

第8章 中東・アフリカのビタミンB12サプリメント市場の見通し、2018年～2031年

第9章 競合情勢

  • メーカーと最終用途産業別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競合ダッシュボード
  • 企業プロファイル
    • Apotheca Inc.
    • Merck Group
    • Charkit Chemical Company LLC
    • Johnlee Pharmaceuticals Pvt. Ltd
    • American Regent, Inc.
    • Koninklijke DSM N.V
    • Bristol-Myers Squibb Company
    • Sanofi-Aventis
    • Pfizer Inc.
    • Chemkart India Pvt. Ltd

第10章 付録

目次

Fairfield Market Research, a leading market intelligence firm, has released its latest comprehensive analysis report on the global Vitamin B12 Supplement market, providing valuable insights into the industry's current status and future trajectory. The report, based on meticulous research and robust data analysis, indicates significant growth prospects for the market, with sales expected to reach US$ 500 Million by the end of 2031, reflecting a projected Compound Annual Growth Rate (CAGR) of 8.0% from 2024 to 2031.

Growing Demand Fueled by Health Awareness and Dietary Trends

The global market for Vitamin B12 Supplements is witnessing notable growth, primarily driven by increasing public awareness of the importance of maintaining healthy lifestyles. Factors such as the rise in vitamin deficiencies, particularly in developing nations, and the growing adoption of veganism have significantly contributed to the surge in demand for these supplements. According to recent studies, the prevalence of vegetarian and vegan diets globally, accounting for 11% and 3% of the population, respectively, underscores the need for alternative sources of Vitamin B12. Additionally, malnutrition-related health issues prevalent in developing countries, as highlighted by the World Health Organization, further underscore the necessity for Vitamin B12 supplementation.

Regional Market Dynamics: Opportunities and Trends

North America: Leading the Charge in Vitamin B12 Supplementation

North America emerges as a prominent market for Vitamin B12 Supplements, with the United States alone projected to witness substantial growth, reaching a market value of US$ 160 Million by 2031. The increasing adoption of vegan and vegetarian diets, coupled with a significant population grappling with digestive disorders, underscores the region's robust demand for these supplements. Canada also presents lucrative opportunities, driven by a sizable population opting for meat-free diets and experiencing digestive health issues.

United Kingdom: Embracing Veganism and Vegetarianism

In the UK, the market for Vitamin B12 Supplements is expected to reach US$ 25.3 Million by 2031, driven by a rising number of individuals embracing vegan and vegetarian lifestyles. Approximately 3% of the population identifies as vegan, while 7% adhere to a vegetarian diet, indicating a growing market for B12 supplements.

India and Germany: Addressing Dietary Deficiencies

India and Germany represent significant markets for Vitamin B12 Supplements, fueled by a substantial portion of their populations adhering to vegetarian or vegan diets. In India, where 24% of the population is vegetarian and 9% vegan, the market is projected to expand steadily throughout the assessment period. Similarly, in Germany, where 3.2% of the population practices veganism, alongside rising concerns over digestive health and mental well-being, the market is poised for significant growth.

End-Use Industries and Product Forms Driving Growth

Fortified Food & Beverage: Meeting Nutritional Needs

The market for Vitamin B12 Supplements through Fortified Food & Beverage is expected to witness robust growth, driven by increasing awareness of health and nutrition. Food fortification presents a cost-effective solution to address nutrient deficiencies, with manufacturers investing in research and development to meet consumer demand for fortified products.

Powder Form: Versatile and Effective

The powder form of Vitamin B12 Supplements is anticipated to experience prominent growth, owing to its water-soluble nature and versatility in addressing various health concerns. With consumers seeking convenient and effective supplementation options, powdered supplements offer a convenient solution for incorporation into beverages, foods, and dietary products.

Competitive Analysis: Innovation and Investment

Leading players in the Vitamin B12 Supplement industry, including Chem Kart India Pvt Ltd, Pfizer Inc., Sanofi-Aventis, and others, are actively engaged in research and development initiatives to enhance product quality and meet evolving consumer preferences. Investment in advanced manufacturing facilities underscores the industry's commitment to addressing global demand for high-quality supplements.

Some key companies are:

  • Chem Kart India Pvt Ltd
  • Pfizer Inc.
  • Sanofi-Aventis
  • Bristol-Myers Squibb Company
  • Konikilijke DSM N.V.
  • Johnlee Pharmaceutical Pvt Ltd.
  • Charkit Chemical.
  • American Regent
  • Apotheca Inc.
  • Merck Group

Segmentation of the Global Vitamin B12 Supplement Market:

By Form

  • Tablet
  • Powder
  • Liquid
  • Capsule

By End Use Industry

  • Fortified Food & Beverages
  • Pharmaceutical
  • Health And Personal Care
  • Agriculture, Animal Feed, Poultry

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Vitamin B12 Supplement Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 3.1. Global Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Tablet
      • 3.1.1.2. Powder
      • 3.1.1.3. Liquid
      • 3.1.1.4. Capsule
  • 3.2. Global Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Fortified Food & Beverages
      • 3.2.1.2. Pharmaceutical
      • 3.2.1.3. Health And Personal Care
      • 3.2.1.4. Agriculture, Animal Feed, Poultry
  • 3.3. Global Vitamin B12 Supplement Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 4.1. North America Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Tablet
      • 4.1.1.2. Powder
      • 4.1.1.3. Liquid
      • 4.1.1.4. Capsule
  • 4.2. North America Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Fortified Food & Beverages
      • 4.2.1.2. Pharmaceutical
      • 4.2.1.3. Health And Personal Care
      • 4.2.1.4. Agriculture, Animal Feed, Poultry
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 4.3.1.2. U.S. Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 4.3.1.3. Canada Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 4.3.1.4. Canada Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 5.1. Europe Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Tablet
      • 5.1.1.2. Powder
      • 5.1.1.3. Liquid
      • 5.1.1.4. Capsule
  • 5.2. Europe Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Fortified Food & Beverages
      • 5.2.1.2. Pharmaceutical
      • 5.2.1.3. Health And Personal Care
      • 5.2.1.4. Agriculture, Animal Feed, Poultry
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.2. Germany Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.3. U.K. Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.4. U.K. Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.5. France Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.6. France Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.7. Italy Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.8. Italy Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.9. Turkey Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.10. Turkey Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.11. Russia Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.12. Russia Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Tablet
      • 6.1.1.2. Powder
      • 6.1.1.3. Liquid
      • 6.1.1.4. Capsule
  • 6.2. Asia Pacific Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Fortified Food & Beverages
      • 6.2.1.2. Pharmaceutical
      • 6.2.1.3. Health And Personal Care
      • 6.2.1.4. Agriculture, Animal Feed, Poultry
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.2. China Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.3. Japan Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.4. Japan Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.5. South Korea Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.6. South Korea Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.7. India Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.8. India Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 7.1. Latin America Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Tablet
      • 7.1.1.2. Powder
      • 7.1.1.3. Liquid
      • 7.1.1.4. Capsule
  • 7.2. Latin America Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Fortified Food & Beverages
      • 7.2.1.2. Pharmaceutical
      • 7.2.1.3. Health And Personal Care
      • 7.2.1.4. Agriculture, Animal Feed, Poultry
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 7.3.1.2. Brazil Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 7.3.1.3. Mexico Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 7.3.1.4. Mexico Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 7.3.1.5. Argentina Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 7.3.1.6. Argentina Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Vitamin B12 Supplement Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Vitamin B12 Supplement Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Tablet
      • 8.1.1.2. Powder
      • 8.1.1.3. Liquid
      • 8.1.1.4. Capsule
  • 8.2. Middle East & Africa Vitamin B12 Supplement Market Outlook, by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Fortified Food & Beverages
      • 8.2.1.2. Pharmaceutical
      • 8.2.1.3. Health And Personal Care
      • 8.2.1.4. Agriculture, Animal Feed, Poultry
  • 8.3. Middle East & Africa Vitamin B12 Supplement Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.2. GCC Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 8.3.1.3. South Africa Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.4. South Africa Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 8.3.1.5. Egypt Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.6. Egypt Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 8.3.1.7. Nigeria Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.8. Nigeria Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Vitamin B12 Supplement Market by Form, Value (US$ Mn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Vitamin B12 Supplement Market by End Use Industry, Value (US$ Mn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by End Use Industry Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Apotheca Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Merck Group
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Charkit Chemical Company LLC
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Johnlee Pharmaceuticals Pvt. Ltd
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. American Regent, Inc.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Koninklijke DSM N.V
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Bristol-Myers Squibb Company
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Sanofi-Aventis
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Pfizer Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Chemkart India Pvt. Ltd
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations